Treatment Approach for Metastatic Intracranial Germinoma: A Multi‐Institutional Experience
Our data show that pre-irradiation induction chemotherapy followed by CSI is associated with excellent overall survival in patients with metastatic germinoma. Importantly, our experience suggests that in combination with induction chemotherapy, 21 Gy CSI may be sufficient as a curative dose in this patient population.
Authors
- David H. Ebb (ORCID: https://orcid.org/0000-0002-6396-8479)
- Torunn Ingrid Yock (ORCID: https://orcid.org/0000-0001-6408-8011)
- Kevin X. Liu (ORCID: https://orcid.org/0000-0003-2071-5137)
- Karen Jean Marcus (ORCID: https://orcid.org/0000-0001-5156-6336)
- Shannon M. MacDonald (ORCID: https://orcid.org/0000-0001-9092-1337)
- Kee Kiat Yeo (ORCID: https://orcid.org/0000-0003-0713-6384)
- Susan Chi (ORCID: https://orcid.org/0000-0001-7753-878X)
- Myrsini Ioakeim‐Ioannidou
- Daphne Adele Haas-Kogan (ORCID: https://orcid.org/0000-0002-2378-4800)
- Karen D. Wright (ORCID: https://orcid.org/0000-0002-9578-1545)
- Phoebe C. Power
- Hesham Elhalawani (ORCID: https://orcid.org/0000-0001-9848-2623)
- Roshan V. Sethi
Institutions
- Brigham and Women's Hospital (US)
- Massachusetts General Hospital (US)
- Dana-Farber Brigham Cancer Center (US)
- Dana-Farber/Boston Children's Cancer and Blood Disorders Center (US)
Publication Details
- Journal
- Pediatric Blood & Cancer
- Published
- 2025-03-04
- DOI
- https://doi.org/10.1002/pbc.31628
- Citations
- 1
- Primary Topic
- Glioma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.63